alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 62, Number 66 (Monday, April 7, 1997)]
[Notices]
[Pages 16542-16543]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-8770]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration
[A-821-807]


Ferrovanadium and Nitrided Vanadium From the Russian Federation; 
Notice of Extension of Time Limit for Antidumping Duty Administrative 
Review

AGENCY: Import Administration, International Trade Administration, 
Department of Commerce.

EFFECTIVE DATE: April 7, 1997.

FOR FURTHER INFORMATION CONTACT:
David Goldberger at (202) 482-4136, or Erik Warga at (202) 482-0922, 
Office of AD/CVD Enforcement, Import Administration, International 
Trade Administration, U.S. Department of Commerce, 14th Street and 
Constitution Avenue, NW, Washington, DC 20230.

Summary: The Department of Commerce (the Department) is extending the 
time limit for the preliminary results of the first administrative 
review of the antidumping duty order on ferrovanadium and nitrided 
vanadium from the Russian Federation. This extension is made pursuant 
to the Tariff Act of 1930, as amended by the Uruguay Round Agreements 
Act (hereinafter, ``the Act'').

Postponement

    Under the Act, the Department may extend the deadline for 
completion of an administrative review if it determines it is not 
practicable to complete the review within the statutory time limit of 
365 days. The Department finds that it is not practicable to complete 
the first administrative review of ferrovanadium and nitrided vanadium 
from the Russian Federation within this time limit.
    In accordance with section 752(a)(3)(A) of the Act, the Department 
will extend the time for completion for the preliminary results of this 
review

[[Page 16543]]

from a 245-day period to no later than a 365-day period.

    Dated: March 28, 1997.
Jeffrey P. Bialos,
Principal Deputy Assistant Secretary for Import Administration.
[FR Doc. 97-8770 Filed 4-4-97; 8:45 am]
BILLING CODE 3510-DS-M
N O T F O RP U B L IC A T IO NIN W E S T ' S H AWA I # I RE P O R T S A N D P A C IF IC RE P O R T E R



### NO. CAAP-20-0000604

IN THE INTERMEDIATE COURT OF APPEALS
O F THE STATE OF HAWAI # I

MAUI ARTS & CULTURAL CENTER, a Hawai # i nonprofit corporation, Plaintiff-Appellee, v. JOSEPH S. TORRES, JR., Defendant-Appellant, and JOHN DOES 1-50; JANE DOES 1-50; DOE CORPORATIONS 1-50; DOE PARTNERSHIPS 1-50; DOE ENTITIES 1-50, and DOE GOVERNMENTAL UNITS 1-50, Defendants

A PPEAL FROM THE CIRCUIT COURT OF THE SECOND CIRCUIT

(CASE NO. 2CC191000093(1))

O RDER APPROVING STIPULATION FOR DISMISSAL OF APPEAL (By: Ginoza, Chief Judge, Nakasone and Fujise, JJ.) Upon consideration of the Stipulation for Dismissal ofAppeal with Prejudice, filed September 15, 2021, by PlaintiffAppellee Maui Arts & Cultural Center, the papers in support, and the record, it appears that (1) the appeal has been docketed; (2) the parties stipulate to dismiss the appeal with prejudice and bear their own attorneys' fees and costs; (3) the stipulation is dated and signed by counsel for all parties appearing in the Electronically Filed Intermediate Court of Appeals CAAP-20-0000604 17-SEP-2021 08:08 AM Dkt. 33 OAWSTN O T F O RP U B L IC A T IO NIN W E S T ' S H AWA I # I RE P O R T S A N D P A C IF IC RE P O R T E R



### appeal; and (4) dismissal is authorized by Hawai # i Rules of Appellate Procedure Rule 42(b).

Therefore, IT IS HEREBY ORDERED that the stipulation is approved and the appeal is dismissed with prejudice. The parties shall bear their own attorneys' fees and costs on appeal.

DATED: Honolulu, Hawai # i, September 17, 2021. /s/ Lisa M. Ginoza Chief Judge /s/ Karen T. Nakasone Associate Judge /s/ Alexa D.M. Fujise Associate Judge

2
# mecs13
#### Lowe v. State

112,017

03/31/2016

Denied.

Unpublished
Exhibit
32(a)


CERTIFICATION
PURSUANT TO 18 U.S.C. § 1350





I, Mark
J. Morrison, the principal executive officer of Hallmark Financial Services,
Inc. (the "Company"), hereby certify that the accompanying report on
Form 10-Q for the quarter ended March 31, 2010, and filed with the
Securities and Exchange Commission on the date hereof (the "Report"), fully
complies with the requirements of Section 13(a) of the Securities Exchange
Act of 1934, as amended. I further certify that the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.





Date:   
        May 13, 2010/s/ Mark J. MorrisonMark
      J. Morrison,Principal
      Executive Officer
#### State v. Rios-Baltazar

110,921

03/28/2016

Denied.

Unpublished
No. 12-5468.

#### Jennings *v.*United States.

C. A. 4th Cir. Certiorari denied.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM RJRN'S
CONSOLIDATED CONDENSED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000083612
<NAME> RJR NABISCO, INC.
<MULTIPLIER> 1,000,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                             251
<SECURITIES>                                         0
<RECEIVABLES>                                    1,413
<ALLOWANCES>                                         0
<INVENTORY>                                      2,636
<CURRENT-ASSETS>                                 4,745
<PP&E>                                           8,837
<DEPRECIATION>                                 (3,002)
<TOTAL-ASSETS>                                  31,260
<CURRENT-LIABILITIES>                            4,124
<BONDS>                                          9,256
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      11,669
<TOTAL-LIABILITY-AND-EQUITY>                    31,260
<SALES>                                         17,063
<TOTAL-REVENUES>                                17,063
<CGS>                                            7,973
<TOTAL-COSTS>                                    7,973
<OTHER-EXPENSES>                                 1,064
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 832
<INCOME-PRETAX>                                  1,288
<INCOME-TAX>                                       619
<INCOME-CONTINUING>                                669
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       666
<EPS-PRIMARY>                                     0.00
<EPS-DILUTED>                                     0.00
        

</TABLE>
##### 



Exhibit 32 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section
1350), each of the undersigned officers of CAM Commerce Solutions, Inc. (the
Company), does hereby certify with respect to the Quarterly Report of the
Company on Form 10-Q for the quarter ended June 30, 2004 as filed with the
Securities and Exchange Commission (the 10-Q Report) that to their knowledge:  (1)
    
    the 10-Q Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and(2)
    
    the information contained in the 10-Q Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company. /s/ Geoffrey D. KnappGeoffrey D. KnappChief Executive OfficerAugust 12, 2004
 /s/ Paul Caceres, Jr.Paul Caceres, Jr.Chief Financial and Accounting OfficerAugust 12, 2004
 This certification accompanies this 10-Q Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
No. 12-5536.

#### Andablo-Saenz *v.*United States.

C. A. 11th Cir. Certiorari denied. .
[Federal Register Volume 62, Number 8 (Monday, January 13, 1997)]
[Notices]
[Pages 1798-1799]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-787]


-----------------------------------------------------------------------


DEPARTMENT OF TRANSPORTATION

Aviation Rulemaking Advisory Committee Meeting on Emergency 
Evacuation Issues

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a public meeting on the FAA's Aviation 
Rulemaking Advisory Committee (ARAC) to discuss emergency evacuation 
issues.

DATES: The meeting will be held on January 30, 1997 at 9:00 a.m. 
Arrange for oral presentations by January 15, 1997.

ADDRESSES: The meeting will be held at McDonnell Douglas, 3855 North 
Lakewood Boulevard, Building 800, Long Beach, CA 90808.

FOR FURTHER INFORMATION CONTACT:
Jackie Smith, Office of Rulemaking, ARM-209, FAA, 800 Independence

[[Page 1799]]

Avenue, SW, Washington, DC 20591, Telephone (202) 267-9682, FAX (202) 
267-5075.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a)(2) of the Federal 
Advisory Committee Act (Pub. L. 92-463; 5 U.S.C. app. III), notice is 
given of an ARAC meeting to be held on January 30, 1997 at McDonnell 
Douglas, 3855 North Lakewood Boulevard, Long Beach, CA 90808.
    The agenda will include:
    <bullet> Opening Remarks.
    <bullet> Review of Action Items.
    <bullet> Report on Performance Standards Working Group Activities.
    Attendance is open to the public, but will be limited to space 
available. The public must make arrangements by January 30, 1997 to 
present oral statements at the meeting. Written statements may be 
presented to the committee at any time by providing 25 copies to the 
Assistant Executive Director for Emergency Evacuation Issues or by 
providing copies at the meeting. In addition, sign and oral 
interpretation, as well as a listening device, can be made available if 
requested 10 calendar days before the meeting. Arrangements may be made 
by contacting the person listed under the heading FOR FURTHER 
INFORMATION CONTACT.

    Issued in Washington, DC, on January 7, 1997.
Ava L. Mims,
Assistant Executive Director for Emergency Evacuation Issues, Aviation 
Rulemaking Advisory Committee.
[FR Doc. 97-787 Filed 1-10-97; 8:45 am]
BILLING CODE 4910-13-M
EX-4.7



 Exhibit 4.7 

Amendment to Check Point Software Technologies Ltd. 

2005 Israel Equity Incentive Plan, dated January 22, 2014 

Effective as of January 22, 2014, the Check Point Software Technologies Ltd. 2005 Israel Equity Incentive Plan (the
“Plan”) is hereby amended as follows (the “Amendment”): 
  

	 	1.	Section 3(a) of the Plan shall be deleted in its entirety and replaced with the following: 


“Subject to the provisions of Section 21 of the Plan, the maximum aggregate number of Shares which may be issued under the Plan
and the Company’s 2005 U.S. Equity Incentive Plan, as amended (the “U.S. Plan”, and collectively with the Plan, the “Equity Plans”)), is 19,000,000 Shares; provided, however, that on December 31st of each year,
commencing December 31, 2014, the number of Reserved and Authorized Shares (as defined below) under the Equity Plans shall be automatically reset on such date to equal 10% of the number of Shares issued and outstanding on such date; provided,
however, that in no event shall the number of Reserved and Authorized Shares be less than the number of Shares reserved and authorized under the Equity Plans for Awards granted under the Plans that are outstanding as of such date. The number of
“Reserved and Authorized Shares” under the Equity Plans shall equal the sum of (i) the number of Shares reserved and authorized under the Equity Plans for outstanding Awards granted under the Equity Plans as of such date, and
(ii) the number of Shares reserved, authorized and available for issuance under the Equity Plans on such date.” 
  

	 	2.	Section 3(c) of the Plan shall be deleted in its entirety and replaced with the following: 


“Intentionally omitted.” 
  

	 	3.	Section 7 of the Plan shall be deleted in its entirety and replaced with the following: 


“Term of Plan. The Plan will become effective upon its adoption by the Board and will remain in effect until terminated
pursuant to Section 23 of the Plan.” 
  

	 	4.	Except as explicitly amended by this Amendment, all other terms of the Plan shall remain in full force and effect.
#### Sanders v. State

109,972

03/28/2016

Denied.

Unpublished
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ROADWAY
EXPRESS, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR
ENDED DECEMBER 31, 1999 (AUDITED) AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          80,797
<SECURITIES>                                         0
<RECEIVABLES>                                  299,599
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               398,336
<PP&E>                                       1,356,533
<DEPRECIATION>                                 976,205
<TOTAL-ASSETS>                                 831,408
<CURRENT-LIABILITIES>                          363,359
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           206
<OTHER-SE>                                     290,749
<TOTAL-LIABILITY-AND-EQUITY>                   831,408
<SALES>                                              0
<TOTAL-REVENUES>                             2,813,214
<CGS>                                                0
<TOTAL-COSTS>                                2,735,998
<OTHER-EXPENSES>                               (2,529)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 79,745
<INCOME-TAX>                                    33,972
<INCOME-CONTINUING>                             45,773
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    45,773
<EPS-BASIC>                                       2.43
<EPS-DILUTED>                                     2.39


</TABLE>
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 301 Agreed to Senate (ATS)]

111th CONGRESS
  1st Session
S. RES. 301

          Designating October 2, 2009, as ``World MRSA Day''.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 5, 2009

    Mr. Burris (for himself and Mr. Durbin) submitted the following 
             resolution; which was considered and agreed to

_______________________________________________________________________

                               RESOLUTION

 
          Designating October 2, 2009, as ``World MRSA Day''.

Whereas methicillin-resistant Staphylococcus aureus (MRSA) causes deadly 
        infections in patients that are receiving treatment in health care 
        facilities and affects numerous individuals within our Nation's 
        communities;
Whereas the Centers for Disease Control and Prevention has estimated that 
        hospital-acquired MRSA infections killed more than 19,000 individuals in 
        the United States in 2006;
Whereas patient and consumer advocacy organizations around the world are lending 
        their voices to a call for leadership and an international commitment to 
        preventing and eradicating MRSA, a disease that has reached pandemic 
        levels and is spreading at an alarming rate;
Whereas patient and consumer advocacy organizations are calling upon health care 
        officials and government leaders to step up and take a more 
        comprehensive approach to stopping MRSA through implementation of a 
        broad and proactive prevention program;
Whereas the MRSA Survivors Network, the first consumer organization in the 
        United States to raise awareness concerning the MRSA epidemic and other 
        such multi-drug resistant health care-acquired infections, has announced 
        that October 2, 2009, has been designated as ``World MRSA Day'', which 
        shall be commemorated annually on such date; and
Whereas the MRSA Survivors Network has also designated the month of October as 
        ``World MRSA Awareness Month'' in order to call attention to this 
        worldwide epidemic: Now, therefore, be it
    Resolved, That the Senate designates October 2, 2009, as ``World 
MRSA Day''.
                                 <all>
```
EXHIBIT 23
                                                                


                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


  As independent public accountants,  we hereby consent to the incorporation
  of our  report dated  February  13, 1996,  on the  consolidated  financial
  statements of Reading & Bates Corporation and subsidiaries as of  December
  31, 1995 and  1994, and for  the years ended December  31, 1995, 1994  and
  1993  included in  this  Form 10-K,  into the  Company's  previously filed
  Registration  Statements (file no.s 33-44237, 33-50828, 33-50565, 33-56029
  and 33-62727).




  Arthur Andersen LLP

  Houston, Texas
  March 8, 1996
No. 12-5947.

#### Chavez-Marquez *v.*United States.

C. A. 5th Cir. Certiorari denied.
[Federal Register Volume 62, Number 63 (Wednesday, April 2, 1997)]
[Notices]
[Page 15716]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-8294]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


National Center for Research Resources; Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Center for Research Resources Special Emphasis Panel (SEP) 
meetings:

    Name of SEP: General Clinical Research Centers.
    Date: May 13-14, 1997.
    Time: 8 a.m.
    Place: Holiday Inn Iowa City, Johnson 1 & 2 Conference Room, 210 
South Dubuque Street, Iowa City, IA 52240, (319) 337-4058.
    Contact Person: Dr. Bela Gulyas, Scientific Review 
Administrator, 6705 Rockledge Drive, MSC 7965, Room 6018, Bethesda, 
MD 20892-7965, (301) 435-0811.

    Name of SEP: Biomedical Research Technology.
    Date: May 27-29, 1997.
    Time: 8 a.m.
    Place: Doubletree Hotel, Conference Rooms--Twinbrook, Montrose, 
and Parklawn, 1750 Rockville Pike, Rockville, MD 20852, (301) 468-
1100.
    Contact Person: Dr. Sharon Moss, Scientific Review 
Administrator, 6705 Rockledge Drive, MSC 7965, Room 6018, Bethesda, 
MD 20892-7965, (301) 435-0811.
    Purpose/Agenda: To evaluate and review grant applications.

    The meetings will be closed in accordance with the provisions 
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program No. 93.371, 
Biomedical Research Technology; 93.333, Clinical Research, National 
Institutes of Health, HHS)

    Dated: March 27, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, National Institutes of Health.
[FR Doc. 97-8294 Filed 4-1-97; 8:45 am]
BILLING CODE 4140-01-M
<PAGE>   1
                                                                    EXHIBIT 11.1

                         STATEMENT REGARDING COMPUTATION
                              OF PER SHARE EARNINGS


<TABLE>
<CAPTION>
Statement Regarding Computation of                        Three months                     Six months
Per Share Earnings                                       ended June 30,                ended June 30, (2)
                                                 ----------------------------      ---------------------------
                                                    2001             2000             2001             2000
                                                 ----------       ----------       ----------       ----------
<S>                                               <C>              <C>              <C>              <C>
Basic net income per share:
  Weighted-average shares outstanding             1,975,723        1,986,315        1,976,372        1,986,315
  Net income per share                           $      .31       $      .53       $      .71       $      .97

Weighted-average common shares
     outstanding and common share
        equivalents (1)                           1,975,723        1,986,315        1,976,372        1,986,315
                                                 ----------       ----------       ----------       ----------

Net income                                       $  610,000       $1,045,000       $1,048,000       $1,922,000
                                                 ==========       ==========       ==========       ==========
Diluted net income per share                     $      .31       $      .53       $      .71       $      .97
                                                 ==========       ==========       ==========       ==========
</TABLE>


(1)      20,000 shares of common stock equivalents were excluded from the
         computation of earnings per share for all periods presented because
         they were antidilutive.
(2)      Average shares outstanding and net income per share for 2000 were
         restated for the stock dividend paid on February 16, 2001.


                                 PAGE 15 OF 15